Citations

Showing 10 of 108094 citations.

Hypersensitiveness to Cold: A Condition Dangerous to Swimmers
Horton, Bayard T., Gabrielson, Milton A.

Mayo Clinic

Research Quarterly. American Association for Health, Physical Education and Recreation | July 11, 2018 | Volume: 11 | Issue: 3 | Pages: 119-125

10.1080/10671188.1940.10627272 Get It

Faculty Opinions recommendation of Oscillatory activity and cortical coherence of the nucleus basalis of Meynert in Parkinson's disease dementia.
Caviness, John N.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 11, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.733079662.793547927 Get It

Internal Fixation of Unstable Osteochondritis Dissecans: Do Open Growth Plates Improve Healing Rate?
Wu, Isabella T. , Desai, Vishal S. , Pareek, Ayoosh , Saris, Daniël B.F. , Krych, Aaron J. , Krych, Aaron J , Custers, Roel J.H. , Desai, Vishal , Stuart, Michael J.

Mayo Clinic

The American Journal of Sports Medicine | July 11, 2018 | Volume: 46 | Issue: 10 | Pages: 2394-2401

10.1177/0363546518783737 | PMID 29995442 Get It

Background: Osteochondritis dissecans (OCD) is a disorder of unknown origin that can affect knees in skeletally mature and immature patients. Surgical management is an important cornerstone of treatment for unstable OCD lesions. Purpose: To determine the (1) healing rate after internal fixation of unstable OCD between skeletally immature and mature knees, (2) risk factors for failure, and (3) patient-reported outcomes among healed patients. Study Design: Cohort study; Level of evidence, 3. Methods: A multicenter retrospective cohort study was conducted with patients who underwent internal fixation of unstable knee OCD lesions from 2000 to 2015. Skeletal immaturity was defined as open or partially open physes. Healing was assessed through clinical findings and imaging. Definitive reoperation for the same OCD lesion was classified as failure. Results: Among 87 patients included, 66 (76%) had healed lesions at ≥2 years postoperatively, while 21 (24%) failed. Skeletal maturity made no significant difference in failure rate (risk ratio, 0.68; 95% CI, 0.29-1.72; P = .40). For skeletally immature patients, lateral versus medial condylar location conferred an increased hazard of 18.2 (95% CI, 1.76-188.07; P < .01). Multivariate analysis factoring in skeletal maturity showed that lateral condylar location was an independent risk factor for failure (hazard ratio, 4.25; 95% CI, 1.47-19.85; P < .01). Mean patient-reported outcome scores (International Knee Documentation Committee [IKDC] and Knee injury and Osteoarthritis Outcome Score [KOOS]) increased significantly after surgery, except the KOOS symptoms score for the skeletally mature group. Final scores (mean ± SD) were as follows at a mean follow-up of 60 months (range, 24-166): IKDC, 83.5 ± 20.2; KOOS pain, 89.7 ± 14.1; KOOS symptoms, 87.4 ± 18.4; KOOS activities of daily living, 93.9 ± 12.7; KOOS sports, 80.7 ± 25.9; KOOS quality of life, 78.9 ± 23.1. Conclusion: Skeletally immature and mature patients heal at comparable rates after internal fixation of OCD lesions, resulting in functional and subjective improvement. Lateral femoral condylar lesion location is an independent risk factor for failure.
A Tentative Weight-Prediction Formula
Highsmith, J. A.

Mayo Clinic

American Physical Education Review | July 11, 2018 | Volume: 33 | Issue: 7 | Pages: 448-450

10.1080/23267224.1928.10652023 Get It

Combination Therapies for Obesity
Camilleri, Michael , Acosta, Andrés

Mayo Clinic

Metabolic Syndrome and Related Disorders | July 11, 2018 | Volume: 16 | Issue: 8 | Pages: 390-394

10.1089/met.2018.0075 | PMID 29993319 Get It

What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?
Adams, J.D. , Vella, Adrian

Mayo Clinic

Metabolic Syndrome and Related Disorders | July 11, 2018 | Volume: 16 | Issue: 8 | Pages: 383-389

10.1089/met.2018.0024 | PMID 29993315 Get It

Cryptic ETV6–PDGFRB fusion in a highly complex rearrangement of chromosomes 1, 5, and 12 due to a chromothripsis-like event in a myelodysplastic syndrome/myeloproliferative neoplasm
Singh, Zeba N. , Richards, Stephanie , Chaer, Firas El , Gudipati, Mary A. , Waters, Elizabeth, Koon, Sarah, Webley, Matthew, Pitel, Beth A. , Hoppman, Nicole L., Baer, Maria R. , Zou, Ying , Pitel, Beth, Pitel, Beth A , Zou, Ying S , Duong, Vu H.

Mayo Clinic

Leukemia & Lymphoma | July 11, 2018 | Volume: 60 | Issue: 5 | Pages: 1304-1307

10.1080/10428194.2018.1480774 | PMID 29992858 Get It

Thumb carpometacarpal arthritis in patients with Ehlers-Danlos Syndrome: non-operative and operative experiences
Chaudhry, Arif, Wagner, Eric R. , Moran, Steven L. , Chaudhry, Arif R, Wagner, Eric R , Hevesi, Mario

Mayo Clinic

Journal of Hand Surgery (European Volume) | July 11, 2018 | Volume: 44 | Issue: 2 | Pages: 161-166

10.1177/1753193418785825 | PMID 29991339 Get It

Ehlers-Danlos Syndrome is a connective tissue disorder that results in joint and generalized tissue hyperlaxity, predisposing patients to early onset arthritis. An institutional database spanning 1999–2016 was reviewed for all patients with symptomatic carpometacarpal arthritis and coexisting Ehlers-Danlos Syndrome, resulting in 14 thumbs amongst nine patients followed clinically for a median of 5.9 years (range 1–15). Patients managed non-operatively demonstrated stable subjective pain and trended towards decreased range of motion over time, whereas patients managed operatively had significant improvements in pain and trended towards increased grip strength. Our findings suggest that patients with Ehlers-Danlos-associated carpometacarpal arthritis can be successfully managed both operatively and non-operatively and that patients with pain refractory to conservative therapy may benefit from relief and increased hand strength following surgical intervention. Level of evidence: IV
Molecular Epidemiology of Factor IX Germline Mutations in Mexican Hispanics: Pattern of Mutation and Potential Founder Effects
Thorland, Erik C., Liu, Jingzhong , Vielhaber, Erica, Kasper, Carol K., Ambríz, R, Paredes, R , Sommer, Steve S., Weinshenker, Brian G. , Ketterling, Rhett P.

Mayo Clinic

Thrombosis and Haemostasis | July 10, 2018 | Volume: 74 | Issue: 06 | Pages: 1416-1422

10.1055/s-0038-1649957 Get It

SummaryGermline mutations in patients with hemophilia B generally have arisen within the past 150 years. Evidence suggests that these germline mutations generally result from endogenous processes. However, a unique pattern would be expected if a population were exposed to a physiologically important germline mutagen since mutagens generally produce characteristic patterns, or “fingerprints”, of mutation. To determine the pattern of mutation in Mexican Hispanics, the regions of likely functional significance in the factor IX gene were screened by di-deoxy fingerprinting (ddF) in 31 families with hemophilia B. Mutations were found in 30 of these families. Haplotype analysis was performed on individuals with identical mutations to help distinguish independent, recurrent mutations from founder effects. Analysis of these 30 mutations, along with 7 mutations reported previously in Mexican Hispanic families, reveals a pattern of independent mutation that is similar to the pattern of mutation observed in 127 U. S. Caucasian families (p = 0.89). These results may reflect either an underlying pattern of germline mutation due to endogenous processes or the presence of an ubiquitous mutagen. Further analyses of the recurrent mutations revealed that two mutations, T296M and R248Q, accounted for 19% of the mutations found in the Mexicans. Haplotype data suggest that the multiple occurrences of T296M and R248Q are associated with founder effects and that screening for these mutations may allow rapid mutation detection and carrier diagnosis in a significant minority of Mexican families with hemophilia B. These two mutations also are associated with founder effects in the U. S. Caucasian population. However, the haplotypes are different in these two populations, indicating independent origins. The occurrence of identical founder mutations in distinct populations provides evidence for the previous hypothesis that the number of different mutations giving rise to mild or borderline mild/moderate hemophilia B is small compared to deleterious mutations causing more severe disease.
Redefining and reinvigorating the role of physics in clinical medicine: A Report from the AAPM Medical Physics 3.0 Ad Hoc Committee
Samei, Ehsan , Pawlicki, Todd , Bourland, Daniel, Chin, Erika, Das, Shiva K., Fox, Mary Kay , Freedman, D. Jay, Hangiandreou, Nicholas J., Jordan, David W. , Martin, Melissa , Pavlicek, William , Pavord, Daniel, Schober, Lisa, Thomadsen, Bruce , Whelan, Brendan , Hangiandreou, Nicholas, Fox, Mary, Miller, Robin June

Mayo Clinic

Medical Physics | July 10, 2018 | Volume: 45 | Issue: 9 | Pages: No page available

10.1002/mp.13087 | PMID 29992598 Get It

Derived from 2 yr of deliberations and community engagement, Medical Physics 3.0 ( MP 3.0) is an effort commissioned by the American Association of Physicists in Medicine ( AAPM ) to devise a framework of strategies by which medical physicists can maintain and improve their integral roles in, and contributions to, health care and its innovation under conditions of rapid change and uncertainty. Toward that goal, MP 3.0 advocates a broadened and refreshed model of sustainable excellence by which medical physicists can and should contribute to health care. The overarching conviction of MP 3.0 is that every healthcare facility can benefit from medical physics and every patient's care can be improved by a medical physicist. This large and expansive challenge necessitates a range of strategies specific to each area of medical physics: clinical practice, research, product development, and education. The present paper offers a summary of the Phase 1 deliberations of the MP 3.0 initiative pertaining to strategic directions of the discipline primarily but not exclusively oriented toward the clinical practice of medical physics in the United States.